Congress has approved legislation introduced in response to COVID-19 pandemic and intended to thwart counterfeit medical equipment and tests from reaching the US market.
H.R. 5663, the Safeguarding Therapeutics Act, approved by the House in September and by the Senate on 8 December,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?